Your browser doesn't support javascript.
loading
In Vitro and In Vivo Studies of a Heminecrolysin Toxin-VEGF Fusion Protein as a Novel Therapeutic for Solid Tumor Targeting.
Naderiyan, Zahra; Sotoudeh, Nazli; Shoari, Alireza; Ghaderi, Hajarossadat; Habibi-Anbouhi, Mahdi; Moazzami, Reza; Cohan, Reza Ahangari; Behdani, Mahdi.
Afiliação
  • Naderiyan Z; Venom and Biotherapeutics Molecules Laboratory, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
  • Sotoudeh N; Venom and Biotherapeutics Molecules Laboratory, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
  • Shoari A; Venom and Biotherapeutics Molecules Laboratory, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
  • Ghaderi H; Venom and Biotherapeutics Molecules Laboratory, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
  • Habibi-Anbouhi M; National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran.
  • Moazzami R; Human Genetics Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Cohan RA; Department of Nanobiotechnology, New Technologies Research Group, Pasteur Institute of Iran, Tehran, Iran.
  • Behdani M; Venom and Biotherapeutics Molecules Laboratory, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. behdani@pasteur.ac.ir.
Mol Biotechnol ; 65(5): 766-773, 2023 May.
Article em En | MEDLINE | ID: mdl-36203034
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunotoxinas / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunotoxinas / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article